Drug Pipeline

Cholestyramine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
2
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-15 NCT06141473
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of…		 overall status: "Recruiting" → "Active Not Recruiting"
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06141473 Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of… Multiple Sclerosis Active, Not Recruiting
Phase 2
NCT05014646 Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in… Smoldering Plasma Cell Myeloma Active, Not Recruiting
Phase 1
NCT06454383 Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer Advanced Pancreatic Adenocarcinoma Recruiting
Sponsors Running Cholestyramine Trials
City of Hope Medical Center (2) Sanofi (1)
Disease Areas
Multiple Myeloma (1) Multiple Sclerosis (1) Pancreatic Cancer (1)
Get alerts when Cholestyramine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free